🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the efficacy of the SGLT2 ...
Status
Completed
Location
Mackay Memorial Hospital
Start Date
2019-04-01
Trial ID
NCT03871621
Treatments Being Tested
Primary Objective: To assess the mean change in HbA1c (glycated haemoglobi...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-30
Trial ID
NCT02954692
Primary objective: \- To evaluate the effect of lixisenatide versus placeb...
Status
Completed
Location
Investigational Site Number 840010
Start Date
2013-06
Trial ID
NCT01798706
Treatments Being Tested
Acute kidney disease (AKD) happens between 7 and 90 days after an initial k...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2024-11-21
Trial ID
NCT06528405
Treatments Being Tested
This trial is conducted globally. The aim of the trial is to investigate ef...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2016-03-28
Trial ID
NCT02730377
The purpose of this study is to compare the risk of serious adverse events ...
Status
Completed
Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Start Date
2018-10-01
Trial ID
NCT04017221
The purpose of this study is to determine whether incretin-based drugs (use...
Status
Completed
Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Start Date
2014-03
Trial ID
NCT02476760
To evaluate the efficacy of fasiglifam 50 mg once daily compared to placebo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02015780
Treatments Being Tested
The main purpose of this study is to compare the effectiveness and safety o...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-09
Trial ID
NCT01421459
The purpose of this study is to determine whether incretin-based drugs (use...
Status
Completed
Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Start Date
2014-03
Trial ID
NCT02475499